Adstar Aktie

WKN: 928247 / ISIN: US00737P1049 / Symbol: ADST

  Kaufen  
Verkaufen
oder
Werbung

Times and Sales (XETRA)

ZeitKursUmsatz
Zur Zeit stehen keine Daten zur Verfügung
weiter
Werbung

Aktuelle News zu

23:50 UhrCAVU HCM Launches Two New Free Integrations to Deliver Greater Value to Clients
23:48 UhrAlkermes Announces Continued Board Refreshment, Including the Appointment of Christopher I. Wright, M.D., Ph.D. to its Board of Directors
23:47 UhrCORNERSTONE BUILDING INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cornerstone Building Brands, ...
23:45 UhrRutgers Cancer Institute of New Jersey and RWJBarnabas Health to Present Expansive, Diverse and Compelling New Cancer Research at the 2022 ASCO Annual Meeting
23:45 UhrThe Wendy's Company Reaffirms 2022 Outlook
23:36 UhrAlkermes Announces Continued Board Refreshment, Including the Appointment of Christopher I. Wright, M.D., Ph.D. to its Board of Directors
23:35 UhrSelenskyj beklagt Zögerlichkeit bei Sanktionen gegen Russland
23:35 UhrItalian court dismisses case against Tenaris’s Chairman and Chief Executive Officer and two other Board members over allegedly improper payments
23:35 UhrCarbon Market: Results of May 18th Auction held between Québec and California
23:32 UhrCantargia presents clinical interim results at ASCO 2022 highlighting the potential of nadunolimab in combination with checkpoint inhibitor
23:30 UhrRestaurant Brands International Inc. to Participate in RBC Capital Markets 2022 Global Consumer & Retail Conference
23:30 UhrRestaurant Brands International Inc. to Participate in RBC Capital Markets 2022 Global Consumer & Retail Conference
23:29 UhrDXC Technology, Lloyd's und IUA verlängern Vertrag zur Unterstützung der Transformation des Londoner Versicherungsmarktes
23:29 UhrAurora Cannabis Inc. Announces US$125 Million Bought Deal Financing
23:29 UhrRutschen die US-Börsen in einen langanhaltenden Bärenmarkt?
23:28 UhrSummit Midstream Partners, LP Announces Adjournment of Annual Meeting and Information for Reconvened Annual Meeting
23:27 Uhr100% AND MLB ALL-STAR FERNANDO TATIS, JR. DEBUT 2022 LIMITED-EDITION SPORT PERFORMANCE EYEWEAR COLLECTION
23:25 UhrNew 'rebel' elopement planner kicks tradition to the curb with all-inclusive service for alternative couples
23:23 UhrUSA weisen Russlands Forderung nach Aufhebung von Sanktionen zurück
23:23 UhrCarisma Therapeutics to Present Latest Data from Phase 1 Clinical Trial of Engineered Macrophage Therapy at 2022 ASCO Annual Meeting
23:16 UhrBGL Announces the Sale of ROCA ACERO S.A. de C.V.
23:16 UhrDouglas Emmett Declares Quarterly Cash Dividend
23:15 UhrVenzee Technologies Updates Schedule Details for Webcast and First Quarter 2022 Financial Release
23:15 UhrCaris Life Sciences to Showcase Extensive Research with Leading Cancer Centers Reflecting Its Commitment to Improving Outcomes for Patients at ASCO 2022
23:15 UhrVenzee Technologies Updates Schedule Details for Webcast and First Quarter 2022 Financial Release
23:12 UhrNASDAQ, S&P 500 & Co: Tesla-Aktie, Apple-Aktie, Amazon-Aktie, Microsoft-Aktie & Co im Fokus: Das sind die Bilanzen der Tech-Riesen in der aktuellen Saison
23:10 UhrProtagonist Therapeutics to Present Updated Phase 2 Rusfertide Clinical Results in Polycythemia Vera (PV) at ASCO 2022
23:10 UhrFür Tesla: Musk sucht auf Twitter nach neuer Rechtsabteilung - und erntet Kritik
23:08 UhrKaryopharm to Present New Selinexor Data at the 2022 American Society of Clinical Oncology Annual Meeting
23:07 UhrNASA Supports Small Business Research to Power Future Exploration
23:05 UhrSILVERCORP REPORTS ADJUSTED EARNINGS OF $52.4 MILLION, $0.30 PER SHARE, AND CASH FLOW FROM OPERATIONS OF $107.4 MILLION FOR FISCAL 2022
23:05 UhrNew Research Demonstrates Genetic Information Can Transform Cancer Care, Guidelines Remain a Barrier to Patient Access
23:05 UhrElevation Oncology to Present Initial Seribantumab Proof-of-Concept Data from Phase 2 CRESTONE Study in Patients with Tumors Harboring NRG1 Fusions at ASCO 2022
23:05 UhrSILVERCORP REPORTS ADJUSTED EARNINGS OF $52.4 MILLION, $0.30 PER SHARE, AND CASH FLOW FROM OPERATIONS OF $107.4 MILLION FOR FISCAL 2022
23:05 UhrPuma Biotechnology Announces Publication of Abstracts on Neratinib for the 2022 ASCO Annual Meeting
23:01 UhrElectra Makes Steady Progress in Q1 2022 Towards Commissioning its Cobalt Refinery
23:01 UhrFDA Flexibilities, Collaboration to Yield Millions of Bottles of Specialized Medical Infant Formula in Coming Months to Increase U.S. Supply
23:01 UhrMILE MARKER INDUSTRIES ANNOUNCES MANAGEMENT CHANGES
23:01 UhrI-Mab Reports Latest Phase 2 Clinical Data of its Differentiated CD73 Antibody Uliledlimab
23:01 UhrGracell Biotechnologies to Present Updated Clinical Data on BCMA/CD19 Dual-Targeting CAR-T GC012F for Relapsed/Refractory Multiple Myeloma at 2022 ASCO Annual Meeting
23:01 UhrElectra Makes Steady Progress in Q1 2022 Towards Commissioning its Cobalt Refinery
23:01 UhrXencor Reports Initial Dose-Escalation Data from Phase 1 Study of XmAb®104, PD-1 x ICOS Bispecific Antibody, in Advanced Solid Tumors
23:01 UhrSpectrum Pharmaceuticals to Present Data at 2022 ASCO Highlighting the Potential Predictive Capabilities of ctDNA as a Biomarker for Poziotinib Treatment Response
23:00 UhrSQI Diagnostics Reports Second Quarter 2022 Results
23:00 UhrTriNet to Participate at the Stifel 2022 Cross Sector Insight Conference
23:00 UhrCTI BioPharma Presents Pivotal Data from Pacritinib Program at the 2022 American Society of Clinical Oncology Annual Meeting
23:00 UhrNext-Generation Immunotherapy Drug Shows Continued Promise in Several Advanced-Stage Cancers
23:00 UhrMARTIN UNIVERSITY ANNOUNCES DATA SECURITY INCIDENT
23:00 UhrLeap Therapeutics to Present Initial Data from the Investigator-Sponsored Study of DKN-01 Plus Docetaxel in Patients with Prostate Cancer at the 2022 ASCO Annual Meeting
23:00 UhrBelong.Life Real-World Patient Research Analyzes the Impact of COVID-19 on Cancer Diagnosis in ASCO 2022 Abstract
finanzen.net zero
finanzen.net zero

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln